Literature DB >> 29070671

Complement Regulatory Protein Factor H Is a Soluble Prion Receptor That Potentiates Peripheral Prion Pathogenesis.

Sarah J Kane1, Taylor K Farley1,2, Elizabeth O Gordon1, Joshua Estep1, Heather R Bender1, Julie A Moreno1, Jason Bartz3, Glenn C Telling1, Matthew C Pickering4, Mark D Zabel5.   

Abstract

Several complement proteins exacerbate prion disease, including C3, C1q, and CD21/35. These proteins of the complement cascade likely increase uptake, trafficking, and retention of prions in the lymphoreticular system, hallmark sites of early prion propagation. Complement regulatory protein factor H (fH) binds modified host proteins and lipids to prevent C3b deposition and, thus, autoimmune cell lysis. Previous reports show that fH binds various conformations of the cellular prion protein, leading us to question the role of fH in prion disease. In this article, we report that transgenic mice lacking Cfh alleles exhibit delayed peripheral prion accumulation, replication, and pathogenesis and onset of terminal disease in a gene-dose manner. We also report a biophysical interaction between purified fH and prion rods enriched from prion-diseased brain. fH also influences prion deposition in brains of infected mice. We conclude from these data and previous findings that the interplay between complement and prions likely involves a complex balance of prion sequestration and destruction via local tissue macrophages, prion trafficking by B and dendritic cells within the lymphoreticular system, intranodal prion replication by B and follicular dendritic cells, and potential prion strain selection by CD21/35 and fH. These findings reveal a novel role for complement-regulatory proteins in prion disease.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29070671      PMCID: PMC5698161          DOI: 10.4049/jimmunol.1701100

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Post-conversion sialylation of prions in lymphoid tissues.

Authors:  Saurabh Srivastava; Natallia Makarava; Elizaveta Katorcha; Regina Savtchenko; Reinhard Brossmer; Ilia V Baskakov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

2.  Immunodetection of PrPSc in spleens of some scrapie-infected sheep but not BSE-infected cows.

Authors:  R A Somerville; C R Birkett; C F Farquhar; N Hunter; W Goldmann; J Dornan; D Grover; R M Hennion; C Percy; J Foster; M Jeffrey
Journal:  J Gen Virol       Date:  1997-09       Impact factor: 3.891

3.  Extraneural prion neuroinvasion without lymphoreticular system infection.

Authors:  Jason C Bartz; Crista Dejoia; Tammy Tucker; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Monitoring immune cells trafficking fluorescent prion rods hours after intraperitoneal infection.

Authors:  Theodore E Johnson; Brady A Michel; Crystal Meyerett; Angela Duffy; Anne Avery; Steven Dow; Mark D Zabel
Journal:  J Vis Exp       Date:  2010-11-19       Impact factor: 1.355

5.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

Authors:  Gregory S Hageman; Don H Anderson; Lincoln V Johnson; Lisa S Hancox; Andrew J Taiber; Lisa I Hardisty; Jill L Hageman; Heather A Stockman; James D Borchardt; Karen M Gehrs; Richard J H Smith; Giuliana Silvestri; Stephen R Russell; Caroline C W Klaver; Irene Barbazetto; Stanley Chang; Lawrence A Yannuzzi; Gaetano R Barile; John C Merriam; R Theodore Smith; Adam K Olsh; Julie Bergeron; Jana Zernant; Joanna E Merriam; Bert Gold; Michael Dean; Rando Allikmets
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

6.  PrP expression in B lymphocytes is not required for prion neuroinvasion.

Authors:  M A Klein; R Frigg; A J Raeber; E Flechsig; I Hegyi; R M Zinkernagel; C Weissmann; A Aguzzi
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

7.  Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.

Authors:  Andreas P Sjöberg; Sofie Nyström; Per Hammarström; Anna M Blom
Journal:  Mol Immunol       Date:  2008-04-11       Impact factor: 4.407

8.  Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.

Authors:  Peter F Zipfel; Matthew Edey; Stefan Heinen; Mihály Józsi; Heiko Richter; Joachim Misselwitz; Bernd Hoppe; Danny Routledge; Lisa Strain; Anne E Hughes; Judith A Goodship; Christoph Licht; Timothy H J Goodship; Christine Skerka
Journal:  PLoS Genet       Date:  2007-02-01       Impact factor: 5.917

10.  Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.

Authors:  Elizaveta Katorcha; Natallia Makarava; Regina Savtchenko; Alessandra D'Azzo; Ilia V Baskakov
Journal:  PLoS Pathog       Date:  2014-09-11       Impact factor: 6.823

View more
  5 in total

Review 1.  How do PrPSc Prions Spread between Host Species, and within Hosts?

Authors:  Neil A Mabbott
Journal:  Pathogens       Date:  2017-11-24

2.  Exosome-enriched fractions from MS B cells induce oligodendrocyte death.

Authors:  Joyce A Benjamins; Liljana Nedelkoska; Hanane Touil; Paul M Stemmer; Nicholas J Carruthers; Bhanu P Jena; Akshata R Naik; Amit Bar-Or; Robert P Lisak
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-04-09

3.  Tissue-specific biochemical differences between chronic wasting disease prions isolated from free-ranging white-tailed deer (Odocoileus virginianus).

Authors:  Kaitlyn Wagner; Robyn Pierce; Elizabeth Gordon; Arielle Hay; Avery Lessard; Glenn C Telling; Jennifer R Ballard; Julie A Moreno; Mark D Zabel
Journal:  J Biol Chem       Date:  2022-03-16       Impact factor: 5.486

4.  Unaltered intravenous prion disease pathogenesis in the temporary absence of marginal zone B cells.

Authors:  Barry M Bradford; Neil A Mabbott
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

Review 5.  The Effects of Immune System Modulation on Prion Disease Susceptibility and Pathogenesis.

Authors:  Neil A Mabbott; Barry M Bradford; Reiss Pal; Rachel Young; David S Donaldson
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.